U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387094) titled 'A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy' on Jan. 28.
Brief Summary: The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
OSA - Obstructive Sleep Apnea
Obesity
Intervention:
DRUG: XW003 injection
subcutaneous injection
DRUG: placebo with matching volume
subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Disclaimer: Curated by HT Syndication....